Phase II study of single agent oral vinorelbine as a first line treatment for postmenopausal patients with locally recurrent or metastatic breast cancer previously treated with anthracycline or taxanes

被引：0
|
作者：
Elebrashi, M. [1 ]
机构：
[1] Mansoura Univ, Clin Oncol, Dakahlia, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
391
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [41] A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)
    Palumbo, Raffaella
    Bernardo, Antonio
    Strada, Maria Rosa
    Poggi, Guido
    Delmonte, Angelo
    Teragni, Cristina
    Frascaroli, Mara
    Bernardo, Giovanni
    ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [42] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Donadio, M
    Ardine, M
    Berruti, A
    Ritorto, G
    Fea, E
    Mistrangelo, M
    Coccorullo, Z
    Bergnolo, P
    Comandone, A
    Bertetto, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 147 - 152
  • [43] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Michela Donadio
    Mara Ardine
    Alfredo Berruti
    Giuliana Ritorto
    Elena Fea
    Marinella Mistrangelo
    Zaira Coccorullo
    Paola Bergnolo
    Alessandro Comandone
    Oscar Bertetto
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 147 - 152
  • [44] Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer
    Petit, Thierry
    Benider, Abdellatif
    Yovine, Alejandro
    Bougnoux, Philippe
    Spaeth, Dominique
    Maindrault-Goebel, Frederique
    Serin, Daniel
    Tigaud, Jean-Dominique
    Eymard, Jean Christophe
    Simon, Helene
    Bertaux, Brigitte
    Brienza, Silvano
    Cvitkovic, Esteban
    ANTI-CANCER DRUGS, 2006, 17 (03) : 337 - 343
  • [45] Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
    Cortes, Javier
    Vahdat, Linda
    Blum, Joanne L.
    Twelves, Chris
    Campone, Mario
    Roche, Henri
    Bachelot, Thomas
    Awada, Ahmad
    Paridaens, Robert
    Goncalves, Anthony
    Shuster, Dale E.
    Wanders, Jantien
    Fang, Fang
    Gurnani, Renuka
    Richmond, Elaine
    Cole, Patricia E.
    Ashworth, Simon
    Allison, Mary Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) : 3922 - 3928
  • [46] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first line treatment in metastatic breast cancer
    Shamseddine, A.
    Bitar, N.
    Dheiny, M.
    Chehal, A.
    Abou Mourad, Y.
    Jalloul, R.
    Dandashi, A.
    Wehbet, M.
    Abu Nasr, T.
    El Saghir, N. S.
    EJC SUPPLEMENTS, 2004, 2 (03): : 131 - 131
  • [47] Phase II study of paclitaxel plus vinorelbine in metastatic breast cancer patients with prior anthracycline exposure
    Martin, M
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 30 - 30
  • [48] First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
    Allouache, D
    Gawande, SR
    Tubiana-Hulin, M
    Tubiana-Mathieu, N
    Piperno-Neumann, S
    Mefti, F
    Bozec, L
    Genot, JY
    BMC CANCER, 2005, 5 (1)
  • [49] First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
    Djelila Allouache
    Sulochana R Gawande
    Michele Tubiana-Hulin
    Nicole Tubiana-Mathieu
    Sophie Piperno-Neumann
    Fawzia Mefti
    Laurence Bozec
    Jean-Yves Genot
    BMC Cancer, 5
  • [50] Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial
    Kim, Sung-Bae
    Yoo, Changhoon
    Ro, Jungsil
    Im, Seock-Ah
    Im, Young-Hyuck
    Kim, Jee Hyun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Song, Hong Suk
    Kang, Seok Yun
    Park, Hee Sook
    Chung, Hyun-Cheol
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 753 - 761
12345